{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-084035","form_type":"8-K","ticker":"SLAB","cik":"0001038074","company_name":"SILICON LABORATORIES INC.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.975909+00:00","generated_at":"2026-06-13T02:10:49.802876+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Silicon Labs Q2 revenue $245M; Q3 guidance $190-210M, non-GAAP EPS $0.45-$0.73","bullets":["Revenue $245M (in-line); Industrial & Commercial record $165M, Home & Life $80M (decline).","GAAP diluted EPS $0.33; non-GAAP diluted EPS $1.04; GAAP gross margin 58.7%.","Q3 guidance: revenue $190-210M, GAAP EPS ($0.08)-$0.20, non-GAAP EPS $0.45-$0.73.","Convertible notes redeemed: $535M cash + 0.9M shares; $184M share repurchases; new $100M buyback authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-084035","json":"https://secwatch.observer/filing/0001104659-23-084035.json","markdown":"https://secwatch.observer/filing/0001104659-23-084035.md","text":"https://secwatch.observer/filing/0001104659-23-084035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1038074/000110465923084035/0001104659-23-084035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1038074/000110465923084035/tm2316678d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:10:49.802876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2fd31240772ba50a560d6d247042f7f0ab099562","claim":"SILICON LABORATORIES INC. reported third-quarter results: revenue between $190 to $210 million, EPS between $(0.08) to $0.20. Guidance initiated.","evidence_excerpt":"The company expects third-quarter revenue to be between $190 to $210 million. The company also estimates the following results: On a GAAP basis: · GAAP gross margin to be 59% · GAAP operating expenses of approximately $120 million · GAAP diluted earnings (loss) per share between $(0.08) to $0.20","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1038074/000110465923084035/0001104659-23-084035-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third-quarter"},{"label":"Revenue","value":"between $190 to $210 million"},{"label":"EPS","value":"between $(0.08) to $0.20"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"581941fe03ba1d4e80163fdda542e169456e78df","claim":"SILICON LABORATORIES INC. reported fiscal quarter ended July 1, 2023 results: revenue $245 million, EPS $0.33.","evidence_excerpt":"Second Quarter Financial Highlights · Revenue was $245 million, in-line with guidance · Industrial & Commercial revenue for the quarter was $165 million · Home & Life revenue for the quarter was $80 million Results on a GAAP basis: · GAAP gross margin was 58.7% · GAAP R&D expenses were $86 million · GAAP SG&A expenses were $41 million · GAAP operating income as a percentage of revenue was 7% · GAAP diluted earnings per share were $0.33","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1038074/000110465923084035/0001104659-23-084035-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter ended July 1, 2023"},{"label":"Revenue","value":"$245 million"},{"label":"EPS","value":"$0.33"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}